Development of a research agenda for the management of metastatic colorectal cancer: Proceedings from a multidisciplinary research consensus panel

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 2, 2012, Pages 153-163

  Janne D'Othée, Bertrand ^a   Sofocleous, Constantinos T ^c   Hanna, Nader ^a   Lewandowski, Robert J ^d   Soulen, Michael C ^e   Vauthey, Jean Nicolas ^g   Cohen, Steven J ^f   Venook, Alan P ^h   Johnson, Matthew S ^j   Kennedy, Andrew S ^k   Murthy, Ravi ^g   Geschwind, Jean Francois ^b   Kee, Stephen T ⁱ  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UCLA MEDICAL CENTER   (United States)

^j INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NORTH CAROLINA STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; IRINOTECAN; OXALIPLATIN;

CANCER SURVIVAL; CHEMOEMBOLIZATION; COLORECTAL CANCER; CONSENSUS; HUMAN; LIVER METASTASIS; MEDICAL RESEARCH; NOTE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COLORECTAL NEOPLASMS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EMBOLIZATION, THERAPEUTIC; HUMANS; RADIOGRAPHY, INTERVENTIONAL; UNITED STATES;

EID: 84863393386     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.12.003     Document Type: Note

References (96)

1. P.F. Engstrom, J.P. Arnoletti, A.B. Benson III NCCN Clinical Practice Guidelines in Oncology: colon cancer J Natl Compr Canc Netw 7 2009 778 831
2. P.F. Engstrom, J.P. Arnoletti, A.B. Benson III NCCN Clinical Practice Guidelines in Oncology: rectal cancer J Natl Compr Canc Netw 7 2009 838 881
3. S. Manfredi, C. Lepage, C. Hatem, O. Coatmeur, J. Faivre, A.M. Bouvier Epidemiology and management of liver metastases from colorectal cancer Ann Surg 244 2006 254 259 (Pubitemid 44305540)
4. P. Vogt, R. Raab, B. Ringe, R. Pichlmayr Resection of synchronous liver metastases from colorectal cancer World J Surg 15 1991 62 67
5. J.S. Tomlinson, W.R. Jarnagin, R.P. DeMatteo Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580 (Pubitemid 350035315)
6. R. Adam The importance of visceral metastasectomy in colorectal cancer Ann Oncol 11 suppl 3 2000 29 36
7. J.Y. Douillard, D. Cunningham, A.D. Roth Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 2000 1041 1047 (Pubitemid 30162806)
8. S. Giacchetti, B. Perpoint, R. Zidani Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 2000 136 147 (Pubitemid 30036347)
9. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342 (Pubitemid 38702844)
10. S. Cascinu, R. Berardi, S. Salvagni A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation Br J Cancer 98 2008 71 76
11. D.K. Owens, K.N. Lohr, D. Atkins Grading the strength of a body of evidence when comparing medical interventions 2009 Agency for Healthcare Research and Quality Rockville, MD
12. J.S. Wagner, M.A. Adson, J.A. Van Heerden, M.H. Adson, D.M. Ilstrup The natural history of hepatic metastases from colorectal cancer A comparison with resective treatment Ann Surg 199 1984 502 508 (Pubitemid 14105105)
13. J.N. Vauthey, A. Chaoui, K.A. Do Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations Surgery 127 2000 512 519 (Pubitemid 30257509)
14. J.N. Vauthey, E.K. Abdalla, D.A. Doherty Body surface area and body weight predict total liver volume in Western adults Liver Transpl 8 2002 233 240 (Pubitemid 34257205)
15. Y. Kishi, E.K. Abdalla, Y.S. Chun Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry Ann Surg 250 2009 540 548
16. E.K. Abdalla, C.C. Barnett, D. Doherty, S.A. Curley, J.N. Vauthey Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization Arch Surg 137 2002 675 680
17. J.N. Vauthey, T.M. Pawlik, E.K. Abdalla Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239 2004 722 730
18. R. Adam, V. Delvart, G. Pascal Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 2004 644 657
19. D. Azoulay, D. Castaing, J. Krissat Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver Ann Surg 232 2000 665 672
20. J.N. Vauthey, T.M. Pawlik, D. Ribero Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases J Clin Oncol 24 2006 2065 2072 (Pubitemid 46622116)
21. D. Zorzi, Y.S. Chun, D.C. Madoff, E.K. Abdalla, J.N. Vauthey Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases Ann Surg Oncol 15 2008 2765 2772
22. K. Kubota, M. Makuuchi, K. Kusaka Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors Hepatology 26 1997 1176 1181 (Pubitemid 27509300)
23. D. Elias, J.F. Ouellet, T. De Baere, P. Lasser, A. Roche Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival Surgery 131 2002 294 299 (Pubitemid 34229782)
24. L. Capussotti, A. Ferrero, L. Vigano, D. Ribero, R. Lo Tesoriere, R. Polastri Major liver resections synchronous with colorectal surgery Ann Surg Oncol 14 2007 195 201 (Pubitemid 44954289)
25. J.S. Bolton, G.M. Fuhrman Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma Ann Surg 231 2000 743 751 (Pubitemid 30249836)
26. A. Brouquet, M.M. Mortenson, J.N. Vauthey Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy? J Am Coll Surg 210 2010 934 941
27. Y. Fong Surgical therapy of hepatic colorectal metastasis CA Cancer J Clin 49 1999 231 255 (Pubitemid 29525144)
28. D.G. Blazer III, Y. Kishi, D.M. Maru Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases J Clin Oncol 26 2008 5344 5351
29. Y.S. Chun, J.N. Vauthey, P. Boonsirikamchai Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases JAMA 302 2009 2338 2344
30. S. Kopetz, G.J. Chang, M.J. Overman Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 2009 3677 3683
31. B. Nordlinger, H. Sorbye, B. Glimelius Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016 (Pubitemid 351392040)
32. R. Adam, P. Bhangui, G. Poston Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 252 2010 774 787
33. J.S. Gold, C. Are, P. Kornprat Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients Ann Surg 247 2008 109 117
34. R. Adam, T. Aloia, J. Figueras LiverMetSurvey: analysis of clinicopathologic factors associated with the efficacy of preoperative chemotherapy in 2,122 patients with colorectal liver metastases J Clin Oncol 24 18 suppl 2006 151s Abstract 3521
35. D. Elias, T. De Baere, T. Smayra, J.F. Ouellet, A. Roche, P. Lasser Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy Br J Surg 89 2002 752 756 (Pubitemid 34595701)
36. T.J. Vogl, R. Straub, K. Eichler, O. Sollner, M.G. Mack Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy - local tumor control rate and survival data Radiology 230 2004 450 458 (Pubitemid 38133806)
37. H. Hur, Y.T. Ko, B.S. Min Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases Am J Surg 197 2009 728 736
38. R. Adam, E.J. Hagopian, M. Linhares A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies Arch Surg 137 2002 1332 1339
39. A.R. Gillams, W.R. Lees Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases J Vasc Interv Radiol 19 2008 712 717
40. T. Helmberger, N. Holzknecht, U. Schopf Radiofrequency ablation of liver metastases Technique and initial results Radiologe 41 2001 69 76 (Pubitemid 32151044)
41. R. Lencioni, O. Goletti, N. Armillotta Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial Eur Radiol 8 1998 1205 1211 (Pubitemid 128662778)
42. T. Livraghi, L. Solbiati, F. Meloni, T. Ierace, S.N. Goldberg, G.S. Gazelle Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach" Cancer 97 2003 3027 3035 (Pubitemid 36676257)
43. C.T. Sofocleous, E.N. Petre, M. Gonen CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy J Vasc Interv Radiol 22 2011 755 761
44. L. Solbiati, T. Livraghi, S.N. Goldberg Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients Radiology 221 2001 159 166 (Pubitemid 32880383)
45. R.R. White, I. Avital, C.T. Sofocleous Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis J Gastrointest Surg 11 2007 256 263
46. A.R. Gillams, W.R. Lees Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation Eur Radiol 19 2009 1206 1213
47. J. Machi, A.J. Oishi, K. Sumida Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management Cancer J 12 2006 318 326 (Pubitemid 44285559)
48. A. Oshowo, A. Gillams, E. Harrison, W.R. Lees, I. Taylor Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases Br J Surg 90 2003 1240 1243 (Pubitemid 37330428)
49. S.M. Sørensen, F.V. Mortensen, D.T. Nielsen Radiofrequency ablation of colorectal liver metastases: long-term survival Acta Radiol 48 2007 253 258 (Pubitemid 46589076)
50. D.S. Lu, N.C. Yu, S.S. Raman Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 2005 954 960 (Pubitemid 40250843)
51. S. Mulier, Y. Ni, J. Jamart, L. Michel, G. Marchal, T. Ruers Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann Surg Oncol 15 2008 144 157
52. R.T. Poon, K.K. Ng, C.M. Lam Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution Ann Surg 239 2004 441 449 (Pubitemid 38372759)
53. C.T. Sofocleous, R.G. Nascimento, L.M. Petrovic Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results Radiology 249 2008 364 374
54. R.T. Poon, N. Borys Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer Future Oncol 7 2011 937 945
55. S.A. Solazzo, M. Ahmed, R. Schor-Bardach Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways Radiology 255 2010 62 74
56. J. Hansler, T.T. Wissniowski, D. Schuppan Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases World J Gastroenterol 12 2006 3716 3721 (Pubitemid 43958380)
57. M.H. Ravindranath, T.F. Wood, D. Soh Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM Cryobiology 45 2002 10 21 (Pubitemid 36005826)
58. Y. Zhang, J. Deng, J. Feng, F. Wu Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound World J Gastroenterol 16 2010 3584 3591
59. N.E. Kemeny, F.D. Melendez, M. Capanu Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma J Clin Oncol 27 2009 3465 3471
60. M. Lorenz, H.H. Muller Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma J Clin Oncol 18 2000 243 254 (Pubitemid 30056411)
61. N.J. Lygidakis, G. Sgourakis, L. Vlachos Metastatic liver disease of colorectal origin: the value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection Results of a prospective randomized study Hepatogastroenterology 48 2001 1685 1691 (Pubitemid 34003504)
62. V. Boige, D. Malka, D. Elias Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure Ann Surg Oncol 15 2008 219 226
63. M.G. House, N.E. Kemeny, M. Gnen Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer Ann Surg 254 2011 851 856
64. H. Ito, C. Are, M. Gnen Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer Ann Surg 247 2008 994 1002 (Pubitemid 351770420)
65. N.E. Kemeny, W.R. Jarnagin, M. Capanu Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer J Clin Oncol 29 2011 884 889
66. N. Kemeny, Y. Huang, A.M. Cohen Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 1999 2039 2048 (Pubitemid 30035952)
67. N.E. Kemeny, M. Gonen Hepatic arterial infusion after liver resection N Engl J Med 352 2005 734 735 (Pubitemid 40239230)
68. P.M. Sanz-Altamira, L.D. Spence, M.S. Huberman Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial Dis Colon Rectum 40 1997 770 775 (Pubitemid 27295046)
69. C. Tellez, A.B. Benson III, M.T. Lyster Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer 82 1998 1250 1259 (Pubitemid 28155386)
70. M. Albert, M.V. Kiefer, W. Sun Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, Ethiodol, and polyvinyl alcohol Cancer 117 2011 343 352
71. T.J. Vogl, T. Gruber, J.O. Balzer, K. Eichler, R. Hammerstingl, S. Zangos Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study Radiology 250 2009 281 289
72. R.C. Martin, J. Joshi, K. Robbins Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 2011 192 198
73. G. Fiorentini, C. Aliberti, M. Tilli Evaluation of a phase III clinical trial comparing transarterial chemoembolisation (TACE) using irinotecan-loaded polyvinyl alcohol microspheres (Debiri) vs systemic chemotherapy FOLFIRI (CT) for the treatment of unresectable metastases to the liver (LM) in patients with advanced colorectal cancer (MCRC) Cardiovasc Intervent Radiol 34 2011 599 Abstract P-286
74. R.J. Lewandowski, K.G. Thurston, J.E. Goin 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135150 Gy as measured by [18F] fluorodeoxyglucose positron emission tomography and computed tomographic imaging J Vasc Interv Radiol 16 2005 1641 1651 (Pubitemid 44431161)
75. T.F. Jakobs, R.T. Hoffmann, K. Dehm Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases J Vasc Interv Radiol 19 2008 1187 1195
76. A.S. Kennedy, D. Coldwell, C. Nutting Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2006 412 425
77. M.F. Mulcahy, R.J. Lewandowski, S.M. Ibrahim Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 2009 1849 1858
78. R. Cianni, C. Urigo, E. Notarianni Radioembolisation using yttrium 90 (Y-90) in patients affected by unresectable hepatic metastases Radiol Med 115 2010 619 633
79. K.A. Evans, M.G. Richardson, N. Pavlakis, D.L. Morris, W. Liauw, L. Bester Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres J Vasc Interv Radiol 21 2010 1521 1526
80. G. Van Hazel, A. Blackwell, J. Anderson Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85 (Pubitemid 39536508)
81. B. Gray, G. Van Hazel, M. Hope Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720 (Pubitemid 34105661)
82. A. Hendlisz, M. Van den Eynde, M. Peeters Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694
83. R.A. Sharma, G.A. Van Hazel, B. Morgan Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106 (Pubitemid 46596762)
84. G.A. van Hazel, N. Pavlakis, D. Goldstein Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy J Clin Oncol 27 2009 4089 4095
85. S. Kosmider, T.H. Tan, D. Yip, R. Dowling, M. Lichtenstein, P. Gibbs Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer J Vasc Interv Radiol 22 2011 780 786
86. R. Seidensticker, T. Denecke, P. Kraus et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases Cardiovasc Intervent Radiol 2011 Jul 29 10.1007/s00270-011-0234-7 [Epub ahead of print]
87. J.A. Ingold, G.B. Reed, H.S. Kaplan, M.A. Bagshaw Radiation hepatitis Am J Roentgenol Radium Ther Nucl Med 93 1965 200 208
88. G.B. Reed Jr, A.J. Cox Jr The human liver after radiation injury A form of veno-occlusive disease Am J Pathol 48 1966 597 611
89. L.A. Dawson, C.J. McGinn, D. Normolle Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies J Clin Oncol 18 2000 2210 2218 (Pubitemid 30350212)
90. T.S. Lawrence, R.K. Ten Haken, M.L. Kessler The use of 3-D dose volume analysis to predict radiation hepatitis Int J Radiat Oncol Biol Phys 23 1992 781 788
91. S.A. Leibel, T.F. Pajak, V. Massullo A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial Int J Radiat Oncol Biol Phys 13 1987 1057 1064 (Pubitemid 17106936)
92. J.M. Robertson, T.S. Lawrence, S. Walker, M.L. Kessler, J.C. Andrews, W.D. Ensminger The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy Int J Radiat Oncol Biol Phys 32 1995 445 450
93. J.C. Cheng, J.K. Wu, C.M. Huang Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease Int J Radiat Oncol Biol Phys 56 2003 229 234 (Pubitemid 36403696)
94. K.K. Herfarth, J. Debus, F. Lohr Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial J Clin Oncol 19 2001 164 170 (Pubitemid 32063493)
95. K.E. Rusthoven, B.D. Kavanagh, H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
96. M.T. Lee, J.J. Kim, R. Dinniwell Phase I study of individualized stereotactic body radiotherapy of liver metastases J Clin Oncol 27 2009 1585 1591